SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Stifel 2014 Healthcare Conference in New York, NY on November 18, 2014.
|Event:||Stifel 2014 Healthcare Conference|
|Date:||Tuesday, November 18, 2014|
|Place:||New York City|
|Time:||11:30 am ET/ 08:30 am PT|
The presentation will be webcast live and archived for 30 days on Zogenix' Investor Relations website at ir.zogenix.com. Management will also be available to participate in one-on-one meetings at the conference.
Zogenix, Inc. (Nasdaq:ZGNX) is a pharmaceutical company committed to developing and commercializing therapies that address specific clinical needs for people living with pain-related conditions and CNS disorders who need innovative treatment alternatives to help them return to normal daily functioning.
CONTACT: Investors Zack Kubow, The Ruth Group 646.536.7020, firstname.lastname@example.orgSource:Zogenix